Biofrontera (BFRI) Stock Statistics & Valuation Metrics

Biofrontera has a market cap or net worth of $6.23M. The enterprise value is $84.44M.

Biofrontera has 9,446,197 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biofrontera’s return on equity (ROE) is -4.01 and return on invested capital (ROIC) is -154.18%.

The current PE Ratio of Biofrontera is -0.34. Biofrontera’s PEG ratio is 0.00.

In the last 12 months, Biofrontera had revenue of 37.30M and earned -17.76M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -11.06M and capital expenditures 44.00K, giving a free cash flow of -11.02M billion.

Biofrontera pays an annual dividend of ―, resulting in a dividend yield of ―

Biofrontera upcoming earnings date is Sep 30, 2025, TBA Not Confirmed.

Biofrontera as a current ratio of 1.72, with Debt / Equity ratio of -126.58%

In the past 12 months, Biofrontera has paid 22.00K in taxes.

Biofrontera EV to EBITDA ratio is -0.35, with an EV/FCF ratio of -0.49.

Biofrontera has $1.78M in cash and marketable securities with $4.86M in debt, giving a net cash position of $3.08M billion.

Gross margin is 52.61%, with operating margin of -46.14%, and net profit margin of -47.61%.

The average price target for Biofrontera is $2.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy